Many Investors Still Treating Gilead: 4 Launches This Year Could Prove Them Wrong
Gilead sits at a crossroads: the HIV backbone remains strong, but a quartet of new launches could reshape the company...
Uncover which travel rewards program is best suited for your needs. Make the most of your rewards and enhance your travel experience.
22,979 articlesGilead sits at a crossroads: the HIV backbone remains strong, but a quartet of new launches could reshape the company...
Eight trade groups push lower capital charges for mortgage servicing rights and advocate for tailored risk weights, a...
The REX AI Equity Premium Income ETF delivers a high headline payout, but its covered-call approach trails the AI ral...
XRP traders are watching a ripple price alert: last signal that historically preceded a major rally. Analysts caution...
Tech stocks retreat as geopolitical tensions escalate and oil climbs, sending the live nasdaq composite: tech lower a...
Apple is taking a guarded AI route, leaning on partnerships and modest capex. The strategy could alter AI investing d...
Netflix is trading well below its latest peak. This article breaks down what the drop means, what history suggests ab...
Bitcoin slipped to a 17-day low as risk-off sentiment reasserted itself in crypto markets. This report shows which as...
An escalating scam shows how fake agents manipulate emotions to steal savings. Learn the warning signs, real-world st...
BluePeak Capital disclosed it sold additional common shares to fund a $40 million bitcoin purchase, even as its total...
A new analysis ties the united states’ trillion national debt to slower job growth for Gen Z and lower wages, project...
Discord ends its contract with Persona Identities after researchers found the vendor's frontend code publicly accessi...